Concern in RS over rise in prices of essential medicines

Opposition seeks govt's response, debate on the matter

Press Trust of India New Delhi
Last Updated : Nov 26 2014 | 12:53 PM IST
The rise in prices of essential medicines, including those used for treatment of tuberculosis, AIDS and diabetes, resulting from price decontrol of 108 drugs was today raised in Rajya Sabha with entire Opposition seeking government's response on the matter.

Raising the issue during Zero Hour, P Rajeeve (CPI-M) said common man was suffering due to hike in prices of essential medicines used to treat tuberculosis, AIDS, diabetes and heart ailments.

He said the price of anti-cancer drug Glivec has gone up from Rs 8,500 to Rs 1.08 lakh while rates of Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615 against Rs 147 earlier. Anti-rabies injection, Kamrab, priced at Rs 2,670 will now cost Rs 7,000.

He said the price shot up after the government directed the National Pharmaceutical Pricing Authority (NPPA), an autonomous body, to withdraw its May 2014 guidelines on drug price control.

"This has happened because of pressure of pharmaceutical companies," he alleged, adding the government is working for monopolies and is totally against common man.

NPPA had capped the prices of these 108 drugs, in addition to the already listed 800 essential drugs, to improve their affordability.

Members for almost all opposition parties associated themselves with the issue.

Anand Sharma (Cong) said the issue raised is a serious matter and there should be a discussion on it in the House.

Noting that the issue concerns poor people who do not have access to life saving medicines, he said, "The House must take note of it and discuss it urgently."

Sitaram Yechury (CPI-M) wanted the government to give an assurance that it will get back to the House on the issue.

Deputy Chairman P J Kurien said it was for the government to respond and he cannot compel it to do so.

Sharad Yadav (JD-U) said a debate is required on the serious issue.

Minister of State for Parliamentary Affairs Mukhtar Abbas Naqvi said the anguish of the members will be conveyed to the minister concerned.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 26 2014 | 12:40 PM IST

Next Story